LyGenesis is a biotechnology company with an organ regeneration technology platform enabling a patient’s lymph nodes to be used as bioreactors to regrow functioning ectopic organs. LyGenesis’ lead preclinical program is focused on liver regeneration for patients with end stage liver disease. Other therapeutic targets for organ regeneration include the thymus, pancreas, and kidney. Privately held, LyGenesis is headquartered in Pittsburgh, Pennsylvania. To learn more, please visit our website at www.lygenesis.com.
Company Details
- Employees
- 7
- Founded
- -
- Address
- Shady Ave, Pittsburgh,pennsylvania,united States
- in****@****sis.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- lygenesis.com
- HQ
- Pittsburgh, Pennsylvania
Lygenesis Questions
Lygenesis's website is lygenesis.com
Lygenesis's LinkedIn profile is https://www.linkedin.com/company/lygenesis
Lygenesis has
7 employees.
View email and phone details for 7
employees at Lygenesis.
Lygenesis's industry is
Biotechnology Research
Lygenesis's top competitors are
Peptilogics,
Juvenescence®,
Imagine Pharma,
Noveome Biotherapeutics, Inc.,
Morphoceuticals,
Iecure, Inc.,
Obsidian Therapeutics,
Carisma Therapeutics,
Nodthera,
Verismo Therapeutics.
Lygenesis's support email address is info@lygenesis.com
Lygenesis's categories are Biotechnology Research
Lygenesis's founding year is 2017
